• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    16.01 Down 0.52(3.15%) Mar 31, 4:00PM EDT
    |Pre-Market : 16.01 4:39PM EDT
    Add to Portfolio
    Prev Close:16.53
    Open:16.44
    Bid:15.02 x 100
    Ask:18.98 x 100
    1y Target Est:27.07
    Beta:5.808
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:16.00 - 16.70
    52wk Range:9.20 - 20.63
    Volume:245,400
    Avg Vol (3m):242,290
    Market Cap:558.91M
    P/E (ttm):N/A
    EPS (ttm):N/A
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    PETXDown 3.15%558.91M
    ZTSDown 1.34%23.18B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):752.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.64
    Quarterly EPS Est (Mar-15) :-0.42
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.77

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback